Navigation Links
Young Survivor and Advocate, Amanda Nixon, Named 2009 Honorary Breast Cancer Survivor by Susan G. Komen for the Cure, San Diego

SAN DIEGO, Sept. 14 /PRNewswire/ -- Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists committed to ending breast cancer forever, has named Amanda Nixon as San Diego's 2009 Honorary Breast Cancer Survivor. Nixon, a young breast cancer survivor, was diagnosed at age 27 after being overlooked by several doctors because of her age and uncommon symptoms. A shy young woman, Nixon had to search deep within herself to find the courage to continue to ask questions, find answers and fight her own battle against breast cancer. Now, it is her mission to empower others to do the same. Nixon will serve as an inspirational spokesperson to help raise awareness of breast cancer screening and education in San Diego County and support Komen San Diego in its mission to eradicate breast cancer forever.

"All of us at Susan G. Komen for the Cure, San Diego, are inspired by Amanda's story," said Laura Farmer, executive director of Susan G. Komen for the Cure, San Diego. "We have recently completed an in-depth community profile, and we found that young women in San Diego County are in need of additional breast cancer resources. As a young survivor, Amanda will assist us in our efforts to build awareness among young women and other women who we have found to be underserved in the past. We are committed to closing the gaps and ensuring all women in San Diego County have equal resources, education and access to care."

Nixon was diagnosed with Inflammatory Breast Cancer (IBC) on January 10, 2006. Now a survivor for almost four years, she is involved with the cause and determined to make an impact. Because of Nixon's unique story, triumphant recovery, and complicated diagnosis, she was recently featured on the television show called "Mystery Diagnosis." IBC represents only 1 in 8 breast cancer cases, so it is hard to point the finger at doctors who most likely will never have to deal with diagnosing someone with this disease. There is little to no research on this type of cancer and most women diagnosed don't survive.

Nixon's initial symptoms were overlooked. Her first signs were some loss of strength in her right arm while she was driving and some pain in her arm, which she assumed was from her fairly recent breast reduction. Then she noticed her right breast felt different than her left breast. According to Nixon: "It felt like there was something inside about the width of a golf ball." She returned to the plastic surgeon that had performed her breast reduction each time something presented itself and was repeatedly dismissed until her breast became engorged, purple, full of dimples, and her nipple inverted. The doctor couldn't dismiss her any longer and sent her to have a diagnostic mammogram and biopsy resulting in a breast cancer diagnoses.

"I went to my doctors with symptoms that should not have been dismissed once, let alone twice or three times. I was shy and naive and basically was treated improperly," said Nixon. "If the pain hadn't gotten so bad, I probably would have hidden the fact that my breast was purple and inflamed until it resulted in my death."

On Sunday, November 1, 2009, Amanda Nixon, along with more than 13,000 San Diegans are expected to unite in Balboa Park for the Thirteenth Annual Susan G. Komen San Diego Race for the Cure(R). A survivor ceremony will be held prior to the race to recognize Nixon as well as other San Diego breast cancer survivors.

For additional information about the San Diego Race for the Cure or Susan G. Komen for the Cure, please visit the national Web site at, or the San Diego Affiliate web site at San Diegans can sign up for the November 1, 2009, San Diego Race for the Cure on the San Diego Affiliate Web site, or by calling In Motion at (760) 692-2900.

About Susan G. Komen for the Cure, San Diego

Since its inception in 1995, more than $8.5 million has been given to local organizations that provide breast cancer education, screening, diagnostics, treatment and patient support for the uninsured or underinsured in San Diego County. Seventy-five percent of every dollar raised stays right here in San Diego County to cover every step in the breast cancer journey -- from education, outreach, mammograms and diagnostics to surgeries, chemotherapy, radiation and material and financial support. The remaining 25% funds international breast cancer research. In fact, next to the U.S. government, Susan G. Komen for the Cure(R) is the largest funder of breast cancer research in the world.

About Susan G. Komen for the Cure

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, the organization has invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.

    Jennifer Borba von Stauffenberg     Rachel Lipsitz
    Olive PR Solutions                  PR Chair, Susan G. Komen for the Cure
    619-955-5285                        858-449-9575

SOURCE Susan G. Komen for the Cure
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. APDA/NPF Young Onset Parkinsons Conference Series Kick-Off in Dallas, October 23-24
2. Alzheimers Gene Affects Brains of Young Adults
3. Young People at High Risk of Death Worldwide
4. FDA Panel Backs Giving HPV Vaccine Gardasil to Young Males
5. Testing Young Athletes for Heart Defects May Save Lives
6. Young Animals May Be Able to Erase Bad Memories
7. Anthem Life & Disability Insurance Company Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope With Losing a Loved One
8. Blue Cross Blue Shield of Georgia Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One
9. Anthem Life Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One
10. Blue Cross Blue Shield of Georgia offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with the Loss of a Loved One
11. Anthem Life & Disability Insurance Company offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with the Loss of a Loved One
Post Your Comments:
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: